News

The Latest

Marken Makes It Happen COVID-19

In these unprecedented times, we are coming together to achieve one shared goal: to beat COVID-19. The Marken team is essential to this pandemic. Our team of industry leading experts have been busy navigating the new normal because now more than ever the pipeline is perso...

  • Marken Makes It Happen COVID-19

    In these unprecedented times, we are coming together to achieve one shared goal: to beat COVID-19. The Marken team is essential to this pandemic. Our team of industry leading experts have been busy navigating the new normal because now more than ever the pipeline is personal. Learn how Marken Makes it Happen to deliver new… Read more »

  • MARKEN ANNOUNCES LAUNCH OF CELL AND GENE CONTROL CENTER

    Addition of Dedicated Facility Offers Control and Visibility for Complex Shipments Research Triangle Park, N.C., August 5, 2020 – Marken today announced the opening of their purpose-built cell and gene control center in North Carolina, USA. Built at Marken’s corporate headquarters, the state-of-the-art facility offers full visibility of all complex cell and gene shipments anywhere… Read more »

  • NEW MARKEN OVERPACKS IMMEDIATELY IDENTIFY TIME CRITICAL SHIPMENTS

    GREEN COLOR WILL INCREASE VISIBILITY Research Triangle Park, N.C., July 30, 2020 – Marken today announced they have transitioned their overpack cartons for all shipments to Marken green in order to draw immediate attention to their time critical shipments.  Designed to increase visibility for high value shipments destined for patients, the global transition is a… Read more »

  • US: Importing COVID-19 Diagnostic Test Kits

    AUTHOR: Reynaldo Roman | Senior Director, Regulatory Compliance COVID-19 diagnostic test kits and other in vitro diagnostic devices (IVDs) are FDA-regulated products that require FDA and Customs and Border Protection (CBP) clearance when imported into the US. The FDA regulates imported medical devices and IVDs. Generally, imported devices must have FDA marketing approval or must… Read more »

  • MARKEN CONTINUES EXPANSION OF GLOBAL FOOTPRINT

    Adding New Depots and Additional Hubs Provides More Agile Solutions for Clients Research Triangle Park, N.C., July 14, 2020 – Marken, the clinical supply chain subsidiary of UPS Healthcare, announced today they are adding a GMP-compliant depot in Los Angeles, California and a new GMP-compliant depot in Kiev, Ukraine. In addition, two GDP-compliant logistics branches… Read more »

  • US: New Export Filing Requirement for Shipments to China, Russia or Venezuela

    AUTHOR: Reynaldo Roman | Senior Director, Regulatory Compliance As of June 29, 2020, exporters of shipments to China, Russia, or Venezuela must comply with a new, mandatory export filing requirement. Any export shipment from the United States to China, Russia, or Venezuela, involving an item classified under an Export Control Classification Number (ECCN), requires an… Read more »

  • MARKEN: KEEP POST-PANDEMIC TRIALS ON TRACK

    How the right clinical supply chain partner helps sponsors avoid trial disruption, now and going forward  Now more than ever, it’s important to store your clinical drugs closer to the patient. Read our latest article on FierceBiotech.com, sponsored by Marken, to learn how you can keep your post-pandemic trials on track. Be proactive with your… Read more »

  • MARKEN DOUBLES GMP FACILITY IN FRANKFURT AND ADDS CRYOGENIC STORAGE SERVICES

    Supply Chain Provider Offers New Storage Options for Cell and Gene Therapies Research Triangle Park, N.C., June 30, 2020 – Marken, the clinical supply chain leader, announced today it will double the space of its GMP facility in Frankfurt to further expand its frozen room storage capabilities in anticipation of the COVID-19 vaccine and storage… Read more »

  • MARKEN LAUNCHES COVID-19 TEST KIT PRODUCTION UNIT

    Miami Branch will Grow to Accommodate the Increased Demand Research Triangle Park, NC, June 9, 2020 – Marken today announced it has begun producing COVID-19 test kits in its Miami facility as an extension of its global supply chain solutions offering. The completed kits are currently shipping and will be distributed throughout the U.S. and… Read more »

  • MARKEN EXPANDS DIRECT TO PATIENT SERVICES IN INDIA TO 94 CITIES

    Patients Receive Treatments at Home While Enrolled in Clinical Trials Research Triangle Park, NC, May 12, 2020 – Marken announced today that their Direct-to-Patient (DTP) distribution services are now actively delivering to and from 94 cities in India and are expected to be available in 110 cities by the end of May. The need to… Read more »

  • Show More